A61P 1 - Drugs for disorders of the alimentary tract or the digestive system

Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
12/2006
12/13/2006	CN1876033A Compound Chinese preparation with gingko, its preparation method and use
12/13/2006	CN1876031A Chinese globe flower injection and preparation method thereof
12/13/2006	CN1876030A A method for preparing toothache-relieving medicine
12/13/2006	CN1876024A Quality control method of pharmaceutical preparation for treating liver and kidney disease
12/13/2006	CN1876021A A pharmaceutical composition for treating biliary tract disease
12/13/2006	CN1876019A An injection containing phenylpropanolid glycosides, its preparation method and use
12/13/2006	CN1876016A Preparation method of compound kuhseng preparation for injection and medical use thereof
12/13/2006	CN1876014A Diarrhea-treating medicine for birds and preparation method thereof
12/13/2006	CN1876007A Asiabell preparation and preparation method thereof
12/13/2006	CN1875995A A vinegar essence, its extraction process and derivative product
12/13/2006	CN1875994A Strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it
12/13/2006	CN1875991A Bee body, pollen, propolis composite health powder
12/13/2006	CN1875982A A composite preparation for treating HP (helicobacter pylori)
12/13/2006	CN1875967A Method for preparing dispersible tablet of sophora alkaloids tannate
12/13/2006	CN1875966A Pharmaceutical combinations and their use in treating gastrointestinal disorders
12/13/2006	CN1875964A Prescription of compound bifenox drop pills and preparation process thereof
12/13/2006	CN1875963A A medicine for treating hepatitis and preparation process thereof
12/13/2006	CN1875962A Prescription of silibinin-n-methylglucamine drop pills and preparation process thereof
12/13/2006	CN1875961A Prescription of liver beneficial 'Fu Fang Yi Gan Ling' drop pills and preparation process thereof
12/13/2006	CN1875950A Compound capsule of glycyrrhzin and preparation method thereof
12/13/2006	CN1289527C Horny cell growth factor mutant with high bioactivity and its preparation process and use thereof
12/13/2006	CN1289510C Antiviral activity possessed compound and preparation method thereof
12/13/2006	CN1289501C Fused heterotricyclic compound, process for preparing compounds and drugs containing the same
12/13/2006	CN1289499C Pirazino (aza) indole derivatives
12/13/2006	CN1289497C 2-(3,5-bis-trifluoromethyl-phenyl)-N-[6-(1.1-dioxo-1 lambda b-thiomorpholin-4-yl)-4-(methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-N-methyl-isobutyramide
12/13/2006	CN1289490C Oxa-and thiazole derivatives useful as antidiabetic and antibesity agents
12/13/2006	CN1289471C 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
12/13/2006	CN1289466C Pharmaceutical compounds
12/13/2006	CN1289146C Nucleic acid vaccine for preventing and treating hepatitis B virus inflammation and its preparation
12/13/2006	CN1289144C Medicine for treating radioactive membrana mucosa damage, repeative aphtha and paradentitis
12/13/2006	CN1289139C Medicine for treating colitis and its preparing method
12/13/2006	CN1289129C Chinese herbal medicine for treating hepatitis
12/13/2006	CN1289120C Plaster for treating initial stage lymphoid tuberculosis
12/13/2006	CN1289112C Stomach-nourishing kidney-supplementing Chinese medicine and production method
12/13/2006	CN1289109C Lidan capsule for treating liver and gall bladder system diseases
12/13/2006	CN1289096C Magnetic gastricantiacids intermediate and its preparing method
12/13/2006	CN1289095C Physiologically balanced ionized acidic solution and methodology for use in wound healing
12/13/2006	CN1289092C Intestine micro ecological regulating agent
12/13/2006	CN1289091C Pharmaceutical composition for treatment of inflammatory conditions and related use
12/13/2006	CN1289090C Highly selective norepinephrine reuptake inhibitors and use thereof in medicament preparation
12/13/2006	CN1289087C Quinoline derivatives as neuropeptide y antagonists
12/13/2006	CN1289085C Nasal spray agent
12/13/2006	CN1289077C Trimebutine maleate tablet and preparing method thereof
12/12/2006	US7148331 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof
12/12/2006	US7148247 Substituted benzoxazoles as estrogenic agents
12/12/2006	US7148234 Use of EP4 receptor ligands in the treatment of IL-6 involved diseases
12/12/2006	US7148208 For therapy and prophylaxis
12/12/2006	US7148206 Methods and compositions for treating flaviviruses and pestiviruses
12/12/2006	US7147876 comprises Aloe vera, Vitamins, mineral concentrate, organic oils concentrate, Chinese herb, essential oil and spice; for medicinal/cosmetic use
12/12/2006	US7147869 Rapidly disintegrating tablet comprising an acid-labile active ingredient
12/12/2006	US7147868 Antacid and laxative tablets
12/12/2006	US7147851 Humanized immunoglobulin reactive with α4β7 integrin
12/12/2006	US7147471 Use of moulding compounds for producing treatment devices
12/12/2006	CA2347741C Thiazole-derivatives
12/12/2006	CA2290531C Pharmaceutical formulation of omeprazole
12/12/2006	CA2286076C Use of 5ht3 antagonists for promoting intestinal lavage
12/12/2006	CA2245926C 7-phenyl-1,4-diazepane compounds, process for their preparation, and pharmaceutical compositions containing them
12/07/2006	WO2006130532A2 Treatment of liver diseases in which iron plays a role in pathogenesis
12/07/2006	WO2006130040A1 Formulation for prophylaxis of oral cavity diseases
12/07/2006	WO2006129877A1 Novel anti-inflammatory agent
12/07/2006	WO2006129859A2 Combinations of a squalene synthase inhibitor and a hmg-coa reductase inhibitor for treating hyperlipidemia
12/07/2006	WO2006129826A1 Novel piperidine derivative
12/07/2006	WO2006129786A1 Methods of diagnosing, preventing and treating infection with hepatitis c virus
12/07/2006	WO2006129784A1 INTERFERON-α REGULATOR
12/07/2006	WO2006129679A1 Spiropiperidine compound and medicinal use thereof
12/07/2006	WO2006129623A1 Thienotriazolodiazepine compound and a medicinal use thereof
12/07/2006	WO2006129587A1 Pharmaceutical composition comprising pyrazolone derivative
12/07/2006	WO2006129479A1 Gastrointestinal drug composition
12/07/2006	WO2006129468A1 Process for preparation of granular oral composition using oligosaccharide solution
12/07/2006	WO2006129393A1 Composition for treating periodontal disease
12/07/2006	WO2006128389A1 Purine derivatives
12/07/2006	WO2006103342A3 Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same
12/07/2006	WO2002102129A3 Process for the preparation of programmed liberation compositions with venlafaxine and the resulting product
12/07/2006	US20060276509 Tripeptidyl peptidase inhibitors
12/07/2006	US20060276488 (Anilino)(halo)pyrimidine derivatives or (anilino)(amino)pyrimidine derivatives; treating rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis.
12/07/2006	US20060276476 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid
12/07/2006	US20060276452 Use of azetidinecarboxamide derivatives in therapy
12/07/2006	US20060276449 depression, anxiety, neurodegenerative disorders, eating disorders, hypertension, gastrointestinal/immunological diseases, drug dependence, epilepsy, cerebral infarction/ischemia/edema, head trauma, inflammation, alopecia; arginine-vasopressin V1b receptor antagonists; metabolic stability
12/07/2006	US20060276439 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
12/07/2006	US20060276432 Lipid-regulating agent and use thereof
12/07/2006	US20060276421 single-stranded oligonucleotide comprising a 5'-end sequence, an intermediate sequence and a 3'-end sequence, both ends having reverse complementarity with the intermediate sequence, intermediate sequence having loops at both ends; phosphate groups are not phosphorothioated; antiinflammatory agent
12/07/2006	US20060276399 Peptide antagonists of zonulin and methods for use of the same
12/07/2006	US20060276388 Hip/pap polypeptide compositions for use in liver regeneration and for the prevention of liver failure
12/07/2006	US20060276384 Peptides and medicinal compositions containing the same
12/07/2006	US20060275289 Preventive or remedy for inflammatory bowel diseases containing anti-cd81 antibody as the active ingredient
12/07/2006	US20060275284 Combination therapy for treatment of autoimmune diseases using b-cell depleting/immunoregulatory antibody combination
12/07/2006	US20060275253 Beta hydroxy short to medium chain fatty acid polymer
12/07/2006	US20060275251 Polymer complexes of glucuronoglucanes
12/07/2006	DE102005025906A1 Use of a guanylhydrazone compound in the manufacture of medicament for the treatment and/or prevention of e.g. acute and chronic hepatitis, liver cirrhosis, liver cell carcinoma, myocarditis, pharyngitis, pneumonia and pericarditis
12/07/2006	CA2815780A1 Use of polydextrose for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
12/07/2006	CA2610274A1 Benzofuran derivatives with therapeutic activities
12/07/2006	CA2609784A1 Novel method of treating hyperlipidemia
12/07/2006	CA2609388A1 Novel piperidine derivative
12/07/2006	CA2608709A1 Treatment of liver diseases in which iron plays a role in pathogenesis
12/06/2006	EP1728857A2 Liver tissue source
12/06/2006	EP1728801A1 Subtype of humanized antibody against interleukin-6 receptor
12/06/2006	EP1728791A1 Composition for solid pharmaceutical preparation of solifenacin or salt thereof
12/06/2006	EP1728512A1 Controlled-leaching preparation and process for producing the same
12/06/2006	EP1728509A1 Periodontal ligament-protecting agent
12/06/2006	EP1728506A1 Coenzyme q composition with long-term persistence in blood

1 ... 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 ... 1258